Recorded Chinese product: 酒石酸长春瑞滨注射液酒石酸长春瑞滨注射液

This is a medicine registration record from NMPA data.本页为国家药监局药品注册记录。

Labeled sections from the recorded Chinese source are included below. English wording is a reference translation when one is on file, not an official English label.本记录未接入产品级适应症/安全性标注字段。

生产企业Manufacturer

主要成分Active Ingredients

药物知识说明

长春瑞滨是一种在国家药监局注册认定的药品。该药品含有长春瑞滨-94d0d793等成分。

该药品关联的活性成分包括:长春瑞滨Changchun Ruibin。这些成分信息来自国家药监局数据库。

该药品标注的生产企业为:北京双鹭药业股份有限公司Chinese legal name: 北京双鹭药业股份有限公司。

您可以探索含有相同成分的其他药品:长春瑞滨-94d0d793成分药品。

本页面内容来自国家药监局数据库,MedicineGraph在此基础上提供关系图谱和知识导航。

Medicine Knowledge

This medicine (original name: 酒石酸长春瑞滨注射液) is a medicine registered with the national drug regulatory authority. It contains recorded ingredients as active ingredient(s).

Active ingredients associated with this product: 长春瑞滨Changchun Ruibin.

Manufacturers recorded for this product: 北京双鹭药业股份有限公司Chinese legal name: 北京双鹭药业股份有限公司.

Explore other medicines containing the same ingredient: 长春瑞滨 productsProducts containing this recorded ingredient.

Source: MedicineGraph authoritative database. Relationships derived from registered product information.

这是什么What is this

  • 通用名/品名Recorded product name: 酒石酸长春瑞滨注射液Recorded Chinese product: 酒石酸长春瑞滨注射液
  • 剂型Dosage form: 注射剂Injection
  • 规格Specification: 1ml:10mg(以长春瑞滨计)Recorded Chinese description: 1ml:10mg(以长春瑞滨计)

本段仅展示注册/说明书已记录的身份属性,不含适应症或用法建议。Identity attributes from registration/leaflet records only; no indications or usage advice.

主要成分Ingredients

生产企业Manufacturer

  • 北京双鹭药业股份有限公司Chinese legal name: 北京双鹭药业股份有限公司

注册信息NMPA approval number

  • 批准文号NMPA approval number: 国药准字H20067722

信息来源Source and scope

国家药品监督管理局(中国)药品注册数据及已接入说明书字段。National Medical Products Administration (China) medicine-registration data and linked leaflet fields.

  • 品名来源Name source: 10多万条药品说明书数据库 (HIGH)Package-insert database (more than 100,000 records) (HIGH)
  • 生产企业来源Manufacturer source: 10多万条药品说明书数据库Package-insert database (more than 100,000 records)
  • 剂型来源Dosage-form source: 10多万条药品说明书数据库Package-insert database (more than 100,000 records)

范围:当前 MedicineGraph 注册记录及已记录的精确关系;非完整目录,亦不构成疗效等同主张,也不支持换用判断。不含适应症/安全性推断。Scope: current MedicineGraph registration records and exact recorded relationships; not a complete catalog and not a claim of therapeutic equivalence. No inferred indications/safety.

本段为已核准说明书原文摘录(非改写、非AI摘要),非正式英文标签,亦不构成用药建议。 Not an official English label and not medical advice. English wording, when shown, is a reference translation of the Chinese source label.

English translation for reference. Translated from the Chinese source label. Not an official English label and not medical advice.

NMPA approval number

国药准字H20067722

Manufacturer

Chinese legal name: 北京双鹭药业股份有限公司 (domestically manufactured)

Indications

English translation unavailable. The original Chinese source label remains available below.

Dosage and administration

English translation unavailable. The original Chinese source label remains available below.

Adverse reactions

English translation unavailable. The original Chinese source label remains available below.

Contraindications

English translation unavailable. The original Chinese source label remains available below.

Precautions

English translation unavailable. The original Chinese source label remains available below.

Storage

English translation unavailable. The original Chinese source label remains available below.

Specification

English translation unavailable. The original Chinese source label remains available below.

中文说明书原文Original Chinese source label

批准文号

国药准字H20067722

生产企业

北京双鹭药业股份有限公司(国产)

适应症

本品用于非小细胞肺癌、转移性乳腺癌、晚期卵巢癌、恶性淋巴瘤等。

用法用量

1.静脉输注,单药治疗用量为每次25~30mg/m2,药物必须溶于生理盐水 (125ml),并在短时间内(15~20分钟)输完,其后沿此静脉输入等量生理盐水以冲洗血管。21天为一周期,分别在第1?8天各给药一次,2~3周期为一疗程。|2.本品可单用或联合化疗。联合用药剂量和给药时间随化疗方案而有所不同。

不良反应

1.剂量限制性毒性为骨髓抑制,表现在粒细胞减少,贫血,偶见血小板降低。|2.其它常见不良反应为恶心、呕吐、脱发。|3.注射静脉出现不同程度的刺激反应,有时可发生静脉炎。|4.神经毒性较长春新碱轻,周围神经毒性一般限于深腱反射消失,感觉异常少见,长期治疗 可出现下肢无力。|5.植物神经毒性主要表现为小肠麻痹引起的便秘,麻痹性肠梗阻罕见。|6.偶见有心律失常、呼吸困难、支气管痉挛、肝功能受损等。

禁忌

严重肝功能不全者禁用。

注意事项

1.肝功能不全时应减少用药剂量。|2.肾功能不全者应慎用。|3.治疗必须在严密的血液学监测下进行,当粒细胞<3000/mm2时应暂停|4.避免药液污染眼球及其他部位一遇污染应立即用水进行冲洗|5.复昔必须严格地经静脉给药静注药外漏可引起局部皮肤反应甚至出现坏死一旦药液 外漏应立即停注局部处理

贮藏

遮光,密闭,在2~8℃保存。

规格

1ml:10mg(以长春瑞滨计)

证据Evidence

  • 批准文号: 国药准字H20067722
  • rights: 本段为已核准说明书原文摘录(非改写、非AI摘要),非正式英文标签,亦不构成用药建议。

信息来源Source and scope

国家药品监督管理局(中国)药品注册数据。National Medical Products Administration (China) medicine-registration data.

范围:当前 MedicineGraph 注册记录及已记录的精确关系;非完整目录,亦不构成疗效等同主张,也不支持换用判断。Scope: current MedicineGraph registration records and exact recorded relationships; not a complete catalog and not a claim of therapeutic equivalence.